Birdwatch Note Rating
2024-05-08 06:27:46 UTC - HELPFUL
Rated by Participant: 249F824553EDA121E17375A13FBFFC47A6BDB5FF2EA19EF24F1E29E84224A4E7
Participant Details
Original Note:
Misleading. Astrazeneca publicized TTS complications in Mar & Jul 2021, not just weeks ago https://www.astrazeneca.com/media-centre/press-releases/2021/update-on-the-safety-of-covid-19-vaccine-astrazeneca.html https://www.astrazeneca.com/media-centre/press-releases/2021/vaxzevria-showed-no-increased-incidence-of-thrombosis-with-thrombocytopenia-after-second-dose.html Astrazeneca admitted it in a Feb 2024 court filing, for the first time in a legal case https://www.pharmaceutical-technology.com/news/astrazeneca-admits-covid-19-vaccine-may-cause-blood-clots-in-very-rare-cases/ It withdrew its vaccine due to lack of market demand. Other vaccines tackle newer variants https://www.theguardian.com/business/article/2024/may/08/astrazeneca-withdraws-covid-19-vaccine-worldwide-citing-surplus-of-newer-vaccines
All Note Details